BD Cheson - Annals of Internal Medicine, 1990 - Am Coll Physicians Add to CiteULike Add to Complore Add to Connotea Add to Del.icio.us Add to Digg
Add to Facebook Add to Reddit Add to Technorati Add to Twitter What's this? ...
Purpose: To review the current therapeutic options for patients with the ... Cited by 78 - Related articles - All 2 versions
- ►bloodjournal.org [PDF] HP Koeffler, D Heitjan, R Mertelsmann, JE … - Blood, 1988 - Am Soc Hematology . Hematology; all rights reserved Copyright 2007 by The American Society of DC
20036. by the American Society of Hematology, 1900 M St, NW, Suite 200,
Washington Blood (print ISSN 0006-4971, online ISSN 1528-0020), is ... Cited by 97 - Related articles - All 4 versions
- ►ascopubs.org [PDF] AF List, HS Garewal, AA Sandberg - Journal of Clinical Oncology, 1990 - jco.ascopubs.org From the Division of Hematology/Oncology, Department of Medicine, University of
Arizona College of Medicine and the Tucson Veterans Administration Medical
Center, Tuc- son; and the Genetics Center of the Southwest Biomedical ... Cited by 66 - Related articles - All 5 versions
FR Appelbaum, J Barrall, R Storb, LD Fisher, … - Annals of Internal Medicine, 1990 - Am Coll Physicians Study Objective: To determine the efficacy of allogeneic bone marrow
transplantation for severe myelodysplasia, and to identify variables predictive
of outcome. ... Setting: A referral-based bone marrow transplant center. Cited by 99 - Related articles - All 3 versions
- ►ascopubs.org [PDF] MR O'donnell, AP Nademanee, DS Snyder, GM … - Journal of Clinical Oncology, 1987 - jco.ascopubs.org Twenty patients (age range, 4 to 48 years; median age, 36 years) with de novo or
drug-induced myelo- dysplastic syndromes or myeloproliferative disorders were
treated with myeloablative immunosuppressive therapy followed by bone ... Cited by 65 - Related articles - All 5 versions
- ►bloodjournal.org [PDF] EC Guinan, NJ Tarbell, R Tantravahi, HJ … - Blood, 1989 - Am Soc Hematology . Hematology; all rights reserved Copyright 2007 by The American Society of DC
20036. by the American Society of Hematology, 1900 M St, NW, Suite 200,
Washington Blood (print ISSN 0006-4971, online ISSN 1528-0020), is ... Cited by 55 - Related articles - All 5 versions
RE Clark, SA Ismail, A Jacobs, H Payne, SA … - Br J Haematol, 1987 - interscience.wiley.com Ninety-eight consecutive patients with myelodysplastic syndrome were randomized
to a treated or a control group, both receiving conventional supportive therapy.
The treated group were given 13-cis-retinoic acid 20 mg/d if marrow blasts ... Cited by 60 - Related articles - All 4 versions
- ►ascopubs.org [PDF] NJ Bunin, JT Casper, C Chitambar, J Hunter, R … - Journal of Clinical Oncology, 1988 - jco.ascopubs.org Six patients with a myelodysplastic syndrome (MDS) were treated with bone marrow
transplantation (BMT) using partially-matched related (3) or unre- lated (3)
donors. Patients' ages ranged from 7 to 31 years (median, 10 years). Bone ... Cited by 36 - Related articles - All 5 versions
H Van Kamp, TC Prinsze-Postema, PM Kluin, … - Br J Haematol, 1991 - interscience.wiley.com SummaryIn a phase II study, 12 patients with a myelodysplastic syndrome (MDS)
and anaemia (nine transfusiondependent) were treated with recombinant human
erythropoietin (rHuEpo) to assess the therapeutic effect on erythropoiesis ... Cited by 43 - Related articles - All 3 versions
T De Witte, F Zwaan, J Hermans, J Vernant, H … - British journal of haematology, 1990 - ncbi.nlm.nih.gov This retrospective survey of the EBMT Leukaemia Working Party describes 78
patients with myelodysplasia (MDS) or secondary acute myelogenous leukaemia
(sAML) who received an allogeneic bone marrow transplant (BMT). The status ... Cited by 121 - Related articles
